IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing bacteriophage-based therapies for cancer.
Industry: Health Care
Latest Trade: $0.72 0.00 (0.0%)
First Day Return: -0.5%
Return from IPO: -96.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/15/2021 |
Offer Price | $19.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $133 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/03/2021 |
Offer Price | $19.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $133 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Citi |
Piper Sandler |
more |
Company Data | |
---|---|
Headquarters | Rockville, MD, United States |
Founded | 1999 |
Employees | 25 |
Website www.senseibio.com |